HSTM.NASDAQHealthstream INC

Form 4: HealthStream Director Reports Stock Transactions

Sentiment:

Insider Transaction Report


Deborah Taylor Tate, a Director at HealthStream Inc., reported transactions involving restricted stock units and common stock.

Summary

  • Deborah Taylor Tate, a Director at HealthStream Inc. (HSTM), has filed a Form 4 detailing changes in her beneficial ownership of company securities.
  • The filing indicates that Ms. Tate holds 21,551 shares of common stock directly.
  • Additionally, she has been granted 3,654 Restricted Share Units (RSUs), which represent the contingent right to receive one share of common stock upon vesting.
  • These RSUs are subject to a three-year vesting schedule, with vesting occurring annually starting May 28, 2027, in three equal installments.
  • The earliest transaction date noted in the filing is May 28, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions and RSU vesting, rather than significant new strategic information or financial performance indicators.

Positives

  • Director Deborah Taylor Tate continues to hold a significant direct ownership of 21,551 shares of HealthStream common stock.
  • The grant of 3,654 RSUs indicates continued incentive alignment between management and shareholders, with vesting tied to continued service.

Risks

  • The vesting of RSUs is contingent upon continued service, meaning any departure from the company before vesting would result in forfeiture of these units.

Future Outlook

The Restricted Share Units are subject to a three-year vesting schedule, with annual installments beginning May 28, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This filing from a HealthStream director is typical for executive compensation and incentive structures within the healthcare technology sector.

Stakeholder Impact

  • Shareholders gain insight into a director's continued investment and compensation structure through RSU grants.
  • Employees may view the RSU vesting schedule as a retention incentive.

Next Steps

  • Vesting of Restricted Share Units on an annual basis starting May 28, 2027, contingent upon continued service.

Key Dates

DateDescription
05/28/2026Earliest transaction date reported.
05/28/2027First annual vesting date for Restricted Share Units.
06/01/2026Date of signature for the Form 4 filing.

Keywords

HealthStream, HSTM, Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSUs, Common Stock, Director, Stock Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.